I. Bruchim

B. Davidson, W. Gotlieb, A. Andersen, 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Advancing Women’s Cancer Care

S. Blank, P. Petignat, I. Bruchim, 2006, Gynäkologisch-geburtshilfliche Rundschau.

Adjuvant therapy for patients with stage I papillary serous endometrial cancer.

A. Alobaid, P. Gauthier, P. Petignat, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Prediction of Endometrial Cancer Recurrence by Using a Novel Machine Learning Algorithm: An Israeli Gynecologic Oncology Group study.

O. Gemer, Z. Vaknin, O. Lavie, 2020, Journal of gynecology obstetrics and human reproduction.

Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement.

B. Piura, O. Gemer, R. Halperin, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Combined Chemotherapy Regimen of Carboplatin and Paclitaxel as Adjuvant Treatment for Papillary Serous and Clear Cell Endometrial Cancer

A. Fishman, M. Altaras, G. Shechter-Maor, 2009, International Journal of Gynecologic Cancer.

Granulocytic sarcoma presenting as tumors of the cervix.

W. Gotlieb, I. Bruchim, M. Brisson, 2005, Gynecologic oncology.

Contribution of sonographic measurement of ovarian volume to diagnosing ovarian tumors in postmenopausal women

R. Halevy, Y. Beyth, R. Tepper, 2004, Journal of clinical ultrasound : JCU.

Post-operative ascites following lymphadenectomy for early stage endometrial cancer.

W. Gotlieb, I. Bruchim, D. Denschlag, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Expression of matrix metalloproteinase‐2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta

P. Bischof, F. Goffin, I. Bruchim, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Cervical cancer in pregnant women: laparoscopic evaluation before delaying treatment.

P. Petignat, O. Irion, I. Bruchim, 2005, European journal of gynaecological oncology.

A. Ferenczy, W. Gotlieb, S. Mahmud, 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Complete hydatidiform mole and a coexistent viable fetus: report of two cases and review of the literature.

D. Kidron, A. Amiel, M. Fejgin, 2000, Gynecologic oncology.

In vitro metformin anti-neoplastic activity in epithelial ovarian cancer.

S. Lau, M. Pollak, W. Gotlieb, 2008, Gynecologic oncology.

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

B. Monk, K. Jardon, I. Vergote, 2019, The New England journal of medicine.

IGF1R Axis Inhibition Restores Dendritic Cell Antitumor Response in Ovarian Cancer

G. Groisman, M. Hallak, I. Bruchim, 2020, Translational oncology.

Impact of BRCA mutations on outcomes among patients with serous endometrial cancer

U. Beller, O. Lavie, Y. Segev, 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis.

E. Franco, M. Tramèr, F. Coutlée, 2007, Gynecologic oncology.

p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy.

H. Werner, I. Bentov, A. Fishman, 2012, European journal of cancer.

BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines

H. Schayek, H. Werner, D. Kidron, 2012, International Journal of Gynecologic Cancer.

Genetic alterations detected by comparative genomic hybridization and recurrence rate in epithelial ovarian carcinoma.

E. Friedman, W. Gotlieb, S. Mahmud, 2009, Cancer genetics and cytogenetics.

The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group study.

M. Volodarsky, O. Gemer, O. Raban, 2019, European journal of obstetrics, gynecology, and reproductive biology.

P06.12: Combination of endometrial thickness and time since menopause in predicting endometrial cancer in women with postmenopausal bleeding

R. Tepper, A. Fishman, I. Bruchim, 2004, Journal of clinical ultrasound : JCU.

Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma.

Adam Shapiro, A. Ferenczy, W. Gotlieb, 2004, Gynecologic oncology.

The diagnosis of endometrial cancer in women with asymptomatic endometrial polyp does not increase survival rates: an israel gynecologic oncology group study.

M. Volodarsky, O. Gemer, Z. Vaknin, 2021, Maturitas.

Postpartum chills phenomenon: Is it a feto‐maternal transfusion reaction?

D. Ravid, M. Fejgin, Y. Gidoni, 2001 .

IGF-1 and BRCA1 signalling pathways in familial cancer.

H. Werner, I. Bruchim, 2012, The Lancet. Oncology.

Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancer

B. Modan, I. Barshack, E. Friedman, 2004, International Journal of Gynecologic Cancer.

Proliferative and signaling activities of insulin analogues in endometrial cancer cells

H. Werner, Z. Laron, D. Weinstein, 2015, Molecular and Cellular Endocrinology.

Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners

H. Werner, A. Fishman, Zohar Attias-Geva, 2013, PloS one.

Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy

H. Werner, I. Bruchim, R. Sarfstein, 2019, Expert opinion on investigational drugs.

Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways

H. Werner, D. Leroith, I. Bruchim, 2016, Front. Oncol..

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway

H. Werner, I. Bruchim, Shilhav Meisel-Sharon, 2018, Molecular Cancer.

Targeting the IGF1 axis in cancer proliferation

H. Werner, I. Bruchim, Z. Attias, 2009, Expert opinion on therapeutic targets.

Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort study

M. Volodarsky, O. Gemer, O. Raban, 2020, Acta obstetricia et gynecologica Scandinavica.

The European Network for Gynaecological Oncological Trial Groups Charta for Privileged Partnership

J. Ledermann, R. Glasspool, I. Vergote, 2015, International Journal of Gynecologic Cancer.

Sonographic appearance of uterine lymphoma: Case report and review of the literature

R. Tepper, R. Hershkovitz, I. Bruchim, 2014, Journal of clinical ultrasound : JCU.

The insulin-like growth factor-I receptor as an oncogene

H. Werner, I. Bruchim, 2009, Archives of physiology and biochemistry.

Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2

E. Flescher, M. Pasmanik-Chor, A. Fishman, 2013, Journal of Molecular Medicine.

Analysis of two topotecan treatment schedules in patients with recurrent ovarian cancer

A. Fishman, I. Bruchim, G. Haran, 2016, Journal of chemotherapy.

IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer.

H. Werner, E. Flescher, I. Bruchim, 2014, Cancer letters.

Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study

O. Gemer, Z. Vaknin, O. Lavie, 2021, International Journal of Gynecological Cancer.

Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancer.

A. Fishman, I. Bruchim, O. Jarchowsky-Dolberg, 2013, European journal of obstetrics, gynecology, and reproductive biology.

Successful response to docetaxel treatment in recurrent ovarian granulosa cell tumor: a case report.

T. Shavit, A. Fishman, I. Bruchim, 2012, European Journal of Gynaecological Oncology.

Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2 trial.

D. Provencher, J. Ledermann, T. Park-Simon, 2017 .

Cancer Genes, Tumor Suppressors, and Regulation of IGF1-R Gene Expression in Cancer

H. Schayek, H. Werner, D. Weinstein, 2012 .

BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma

E. Friedman, H. Werner, A. Fishman, 2010, International Journal of Gynecologic Cancer.

ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease

H. Werner, S. Yakar, Z. Laron, 2021, Frontiers in Endocrinology.

Preoperative clinical and radiological features of metastatic ovarian tumors

R. Tepper, A. Fishman, I. Bruchim, 2013, Archives of Gynecology and Obstetrics.

Increased ultrasonographic endometrial thickness is associated with poor survival in patients with endometrial cancer: An Israel gynecologic oncology group study.

M. Volodarsky, O. Gemer, O. Raban, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia

A. Fishman, I. Bruchim, D. Kristt, 2010, Diagnostic pathology.

The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches

H. Werner, I. Bruchim, R. Sarfstein, 2014, Front. Endocrinol..

Endometriosis-related Hemoperitoneum in Late Pregnancy.

R. Gabbay-Benziv, M. Hallak, I. Bruchim, 2019, The Israel Medical Association journal : IMAJ.

Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action

H. Werner, Z. Laron, M. Pasmanik-Chor, 2018, Front. Endocrinol..

Minimally invasive approach in endometrial cancer with lower uterine segment involvement in stage ≥ II: A retrospective study.

O. Gemer, L. Kogan, Z. Vaknin, 2021, European journal of obstetrics, gynecology, and reproductive biology.

Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study.

M. Frey, F. Muggia, T. Safra, 2021, Gynecologic Oncology.

In vitro metformin antineoplastic activity in epithelial ovarian cancer

S. Lau, M. Pollak, W. Gotlieb, 2008 .

Does sentinel lymph node biopsy in endometrial cancer surgery have an impact on the rate of adjuvant post operative pelvic radiation? An Israeli Gynecologic Oncology Group Study

O. Gemer, Z. Vaknin, O. Lavie, 2022, Gynecologic oncology reports.

An Israeli Gynecologic Oncology Group study of statin use and endometrial cancer prognosis

O. Gemer, O. Raban, Z. Vaknin, 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancer.

H. Werner, A. Fishman, Zohar Attias-Geva, 2013, Cancer letters.

Targeting IGF-1 signaling pathways in gynecologic malignancies

H. Werner, I. Bruchim, 2013, Expert opinion on therapeutic targets.

Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines.

H. Werner, I. Bentov, A. Fishman, 2011, Gynecologic oncology.

Basic and clinical significance of IGF-I-induced signatures in cancer

H. Werner, I. Bruchim, 2010, BMC medicine.

Sonographic Diagnosis of Uterine Ewing Sarcoma

R. Tepper, A. Fishman, R. Hershkovitz, 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Sarcoma post-embolization for presumed uterine fibroids.

A. Ferenczy, S. Lau, W. Gotlieb, 2008, Gynecologic oncology.

Carboplatin hypersensitivity: evaluation and successful desensitization protocol.

A. Fishman, I. Bruchim, R. Confino‐Cohen, 2014, Immunotherapy.

Cesarean scar pregnancy managed with local and systemic methotrexate: A single center case series.

A. Shrim, E. Shalom-Paz, M. Hallak, 2019, European journal of obstetrics, gynecology, and reproductive biology.

Oncogenic fusion proteins adopt the insulin-like growth factor signaling pathway

H. Werner, I. Bruchim, Shilhav Meisel-Sharon, 2018, Molecular Cancer.

Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer

B. Piura, O. Gemer, R. Halperin, 2016, American journal of clinical oncology.

941TiPENGOT-OV16/NOVA: A PHASE 3 RANDOMIZED DOUBLE-BLIND TRIAL OF MAINTENANCE WITH PARP-INHIBITOR NIRAPARIB VERSUS PLACEBO IN PATIENTS WITH PLATINUM-SENSITIVE OVARIAN CANCER.

B. Monk, A. Oza, R. Wenham, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.